Pegfilgrastim for the management of neutropenia during neoadjuvant chemotherapy with docetaxel, cisp...
Pegfilgrastim for the management of neutropenia during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer patients
About this item
Full title
Author / Creator
Yoshimoto, Takanori , Oshima, Tadayuki , Fukada, Takashi , Imamura, Nobuko , Nakanishi, Takashi , Ebisutani, Nobuhiko , Morishita, Daisuke , Mieno, Masatoshi , Nakai, Keisuke , Sei, Hiroo , Kitayama, Yoshitaka , Eda, Hirotsugu , Okugawa, Takuya , Tomita, Toshihiko , Fukui, Hirokazu and Shinzaki, Shinichiro
Publisher
Singapore: Springer Nature Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Nature Singapore
Subjects
More information
Scope and Contents
Contents
Background
Neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (DCF) therapy is a new standard for locally advanced esophageal squamous cell carcinoma. The optimal timing of pegfilgrastim with the DCF regimen to prevent febrile neutropenia (FN) remains controversial. The effectiveness of concomitant pegfilgrastim administration with continuous...
Alternative Titles
Full title
Pegfilgrastim for the management of neutropenia during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2902963572
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2902963572
Other Identifiers
ISSN
1341-9625
E-ISSN
1437-7772
DOI
10.1007/s10147-023-02438-3
